Mesh Bio

Bukit Merah, Singapore

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.

$3.5M raised

Oct 2023

Series A

Top Investors

Seed CapitalEast VenturesElev8.VCSeeds CapitalSelvedge Venture

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mesh Bio raised?

Mesh Bio has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Mesh Bio's investors?

Mesh Bio's investors include Seed Capital, East Ventures, Elev8.VC, Seeds Capital, Selvedge Venture.

Where is Mesh Bio headquartered?

Mesh Bio is headquartered in Bukit Merah, Singapore.

What does Mesh Bio do?

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.

What stage is Mesh Bio at?

Mesh Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 12, 2023.

MLA

"Mesh Bio — Funding & Investors." VCBacked, October 12, 2023, https://www.vcbacked.co/company/mesh-bio. Accessed June 4, 2026.

APA

VCBacked. (2023). Mesh Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mesh-bio

Wikipedia (cite web)

{{cite web |title=Mesh Bio — Funding & Investors |url=https://www.vcbacked.co/company/mesh-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 12, 2023.